Table 1

Comparison of clinical features in patients 1 and 2 and the family reported by Weedon et al22 with the axonal (type 2) form of Charcot-Marie-Tooth (CMT2) disease22

Patient 1 (age 5 years)Patient 2 (age 51 years)CMT2 family22
Clinical features
 ID/DD/LDSevere IDSevere ID4/13 DD or LD
 Neuronal migration defectMildSevereNot documented
 Delayed motor milestonesYesYes, never learnt to walk9/13
 EpilepsyNoYesNot reported
 Gait abnormalities (waddling and/or broad based, frequent falls)YesCannot walk5/13
 Reduced reflexesYesNot tested7/13
 Hypotonia and/or lordosisYesNo, hypertonia13/13
 ClubfeetNoYes7/13
  • DD, global developmental delay; ID, intellectual disability; LD, learning difficulties and/or language delay.